U.S. Entertainment Stock News

NasdaqGM:SUPN
NasdaqGM:SUPNPharmaceuticals

Supernus Pharmaceuticals (SUPN) Is Up 7.6% After Record Sales But 2025 Net Loss And Cautious 2026 Outlook

In February 2026, Supernus Pharmaceuticals reported fourth-quarter 2025 revenue of US$211.57 million and record full-year 2025 revenue of US$718.95 million, but swung to a full-year net loss of US$38.55 million and guided 2026 operating earnings to a range of US$0–US$30 million on expected total revenues of US$840–US$870 million. The results highlighted strong contributions from newer CNS products such as Qelbree, GOCOVRI, ZURZUVAE, and newly approved ONAPGO, alongside the completed Sage...
NYSE:PAG
NYSE:PAGSpecialty Retail

A Look At Penske Automotive Group (PAG) Valuation After Recent Range Bound Trading

Penske Automotive Group (PAG) has been trading in a relatively tight range, with a modest move over the past month and a slight decline over the past 3 months, prompting fresh interest in its valuation. See our latest analysis for Penske Automotive Group. While the share price has eased in the past week and quarter, the roughly flat year to date share price return sits alongside a 5 year total shareholder return of 127.95%, suggesting longer term holders have still seen strong compounding. If...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Pool Highlights Resilience As Growth Shifts To Maintenance And Buybacks

Pool Corporation (NasdaqGS:POOL) is highlighting its resilience in a tough pool industry backdrop, with flat revenues and weakness in new pool construction. The company is leaning on pricing discipline, supply chain initiatives, and digital efforts to support gross margins and customer service. Ongoing acquisition activity remains part of Pool's growth playbook as it looks to expand its reach and capabilities. Pool, a major distributor of swimming pool supplies, equipment, and related...
NasdaqCM:THRY
NasdaqCM:THRYMedia

Is Thryv (THRY) Quietly Rewriting Its Story With ESOP Shares And Improving SaaS Margins?

In late February 2026, Thryv Holdings filed an US$8.15 million shelf registration for 2,179,185 common shares tied to its ESOP and reported fourth-quarter 2025 results showing quarterly sales of US$191.62 million, a net loss of US$9.66 million, and full-year 2025 sales of US$785.02 million with net income of US$0.31 million. Beyond the headline figures, the results underscored Thryv’s rapid pivot toward higher-margin SaaS and AI-powered tools, with SaaS revenue rising sharply, margins...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

Is OPCH’s Enlarged Buyback and Reaffirmed 2026 Outlook Reframing Its Capital Return Story?

Option Care Health, Inc. recently reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$1,465.45 million while net income eased slightly to US$58.5 million, and full-year sales increasing to US$5.65 billion alongside modestly higher earnings per share from continuing operations. Alongside these results, the company reaffirmed its 2026 outlook and expanded its share repurchase authorization to US$1 billion, highlighting management’s focus on capital returns even...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Acadia Healthcare Company (ACHC) Is Up 39.6% After Massive Goodwill Impairment And Cautious 2026 Guidance – Has The Bull Case Changed?

In the fourth quarter and full year 2025, Acadia Healthcare reported higher revenue but swung to a net loss after recording a very large, non-cash goodwill impairment charge of US$996.2 million and issuing 2026 revenue guidance of US$3.37 billion to US$3.45 billion with flat to 1% same-facility volume growth. Management is pivoting from rapid bed expansion to sharpening operational performance at newer facilities, while also managing pressure from New York Medicaid policy changes that are...
NasdaqGM:GDS
NasdaqGM:GDSIT

A Look At GDS Holdings (NasdaqGM:GDS) Valuation After Recent Share Price Volatility

GDS Holdings (NasdaqGM:GDS) has drawn attention after recent share price swings, with a 1 day decline of 1.1% and an 8.4% drop over the past week reshaping short term sentiment. See our latest analysis for GDS Holdings. The recent 1 day and 1 week share price declines come after a stronger 90 day share price return of 21.61% and a 1 year total shareholder return of 8.57%. This may hint at cooling momentum following a solid rebound phase. If GDS Holdings has you thinking about where...
NasdaqGS:FHB
NasdaqGS:FHBBanks

Is First Hawaiian (FHB) Using Segment Realignment And Buybacks To Quietly Redefine Its Core Strategy?

First Hawaiian, Inc. recently filed its 2025 10-K, detailing a shift to two core segments, Retail Banking and Commercial Banking, alongside US$129.9 million in dividends and US$100.0 million in share repurchases, reinforcing its current capital allocation priorities. The combination of segment realignment and sizeable capital returns highlights how management is repositioning the bank’s business mix while returning excess capital to shareholders. Next, we’ll examine how the new Retail and...
NYSE:CBZ
NYSE:CBZProfessional Services

Is CBIZ’s Slowing Organic Growth And Cautious Outlook Altering The Investment Case For CBIZ (CBZ)?

In February 2026, CBIZ, Inc. reported fourth-quarter 2025 results showing sales of US$542.66 million and a net loss of US$79.42 million, alongside full-year 2025 sales of US$2.76 billion and net income of US$115.44 million, and issued 2026 revenue guidance of US$2.8 billion to US$2.9 billion while expanding its share repurchase activity. Beneath the strong headline growth driven by acquisitions such as Marcum, investors focused on weak organic expansion, margin pressure, and cautious 2026...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Assessing Arrowhead Pharmaceuticals (ARWR) Valuation As Its RNAi Pipeline Advances To Phase 3 With Big Pharma Partners

Arrowhead Pharmaceuticals (ARWR) is back in focus as investors react to progress in its RNA interference drug pipeline, including two therapies in Phase 3 trials and multiple partnerships with large pharmaceutical partners. See our latest analysis for Arrowhead Pharmaceuticals. The recent excitement around Arrowhead’s RNAi pipeline and partnerships comes after a choppy few weeks for the stock, with a 1 month share price return of an 8.74% decline but a 90 day share price return of 12.48%...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

PROCEPT BioRobotics (PRCT) Is Down 16.8% After Cutting 2026 Outlook And Widening Q4 Losses

In late February 2026, PROCEPT BioRobotics reported Q4 2025 results showing sales rising to US$76.38 million but a wider quarterly net loss of US$29.85 million, alongside resetting 2026 revenue guidance to US$390 million–US$410 million and issuing new 2027 targets that include 25%–30% revenue growth and a 68%–70% gross margin. While the company pointed to record procedure volumes, stronger handpiece pricing and a path toward improved margins, investors also had to weigh a larger loss profile...
NYSE:EXPD
NYSE:EXPDLogistics

A Look At Expeditors (EXPD) Valuation After New US$3b Buyback And 2025 Earnings Release

Expeditors International of Washington (EXPD) is back in focus after pairing its full year 2025 earnings release with a new US$3b share repurchase authorization, a combination that directly affects capital returns and investor sentiment. See our latest analysis for Expeditors International of Washington. The latest news lands after a choppy few weeks for the stock, with a 7 day share price return of a 7.21% decline and a 30 day share price return of a 9.66% decline. Even so, the 1 year total...
NYSE:NOMD
NYSE:NOMDFood

Can Nomad Foods’ (NOMD) Heavy Buybacks and 2026 Reset Realign Its Frozen Food Strategy?

In February 2026, Nomad Foods reported fourth-quarter 2025 results showing sales of €773.1 million versus €793.4 million a year earlier and a net loss of €10.7 million, while completing a €348.46 million buyback that retired 21,397,779 shares, or 13.85% of its share count under a program launched in 2023. Management framed 2026 as a transition year with planned price increases, especially in Fish, and organizational restructuring that are expected to pressure near-term organic sales and...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

A Look At Fortrea Holdings (FTRE) Valuation After Weak Q4 Results And Soft 2025–2026 Guidance

Fortrea Holdings (FTRE) shares came under pressure after the contract research group reported fourth quarter 2025 results with revenue and adjusted earnings below analyst forecasts, along with full year 2025 and 2026 guidance that trailed market expectations. See our latest analysis for Fortrea Holdings. At a share price of US$10.72, Fortrea has recorded a sharp 30 day share price return of a 37.13% decline and a 1 year total shareholder return of a 22.60% loss. This suggests momentum has...
NYSE:FNB
NYSE:FNBBanks

Why F.N.B (FNB) Is Down 7.3% After Inflation Jitters Spark Sector-Wide Credit Risk Fears

In late February 2026, F.N.B. Corporation faced pressure alongside other banks after hotter-than-expected US producer inflation data and growing credit risk concerns reduced investors’ confidence in rate-cut prospects and the sector’s loan quality. At the same time, F.N.B. was named to TIME’s list of America’s Best Financial Services 2026 and collected 14 Crisil Coalition Greenwich Best Bank Awards, underscoring its reputation for client-focused commercial banking despite these...
NYSE:EHC
NYSE:EHCHealthcare

Is Dividend Stability And Fresh Accolades Altering The Investment Case For Encompass Health (EHC)?

Encompass Health has recently declared a quarterly cash dividend of US$0.19 per share, payable on April 15, 2026, and confirmed senior leadership participation in the March 2026 Barclays Global Healthcare Conference, while also earning placement on Fortune’s 2026 World’s Most Admired Companies and Forbes’ 2026 America’s Best Companies lists. This combination of steady capital returns, visible investor outreach, and repeated recognition for corporate quality highlights how the company is...
NasdaqGS:MLCO
NasdaqGS:MLCOHospitality

A Look At Melco Resorts & Entertainment (NasdaqGS:MLCO) Valuation After New Global Sustainability Recognition

Melco Resorts & Entertainment (MLCO) just picked up fresh ESG recognition, securing a place in the S&P Global Sustainability Yearbook 2026 with a 96th percentile industry ranking and an improved CDP Water score. See our latest analysis for Melco Resorts & Entertainment. That ESG recognition arrives at a tricky point for the stock, with the share price at US$5.94 after a roughly 37% 3 month share price decline and a 1 year total shareholder return of about 7%. Recent momentum looks weak even...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Will Strong Q4 2025 Results and Impairment Charge Reframe Henry Schein's (HSIC) Investment Narrative?

In February 2026, Henry Schein reported fourth-quarter 2025 results showing sales of US$3,437 million and net income of US$101 million, alongside a US$15 million intangible asset impairment charge. These results capped a year of higher sales and earnings per share, supported by strong contributions from equipment, specialty products, technology businesses, and ongoing share repurchases totaling about US$2.97 billion since 2018. Given this combination of robust quarterly revenue growth and...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

What NetApp (NTAP)'s Strong Q3 Results and Guidance Reveal About Its AI Hybrid-Cloud Ambitions

NetApp, Inc. recently reported fiscal third-quarter 2026 results showing higher revenue of US$1.713 billion and net income of US$334 million year on year, while also declaring a quarterly dividend of US$0.52 per share payable on April 22, 2026. The company paired these results with guidance calling for fourth-quarter 2026 revenue of US$1.795 billion–US$1.945 billion and earnings per share of US$1.76–US$1.86, highlighting momentum in all-flash storage and its Keystone Storage-as-a-Service...
NYSE:NPO
NYSE:NPOMachinery

Assessing Enpro (NPO) Valuation After Earnings, Guidance And Acquisition Plans

Why Enpro's latest earnings and acquisition plans matter for investors Enpro (NPO) has just combined a mixed fourth quarter, with a net loss alongside higher sales, with new 2026 revenue guidance and fresh comments about pursuing acquisitions to support its Enpro 3.0 strategy. See our latest analysis for Enpro. Despite the recent quarterly net loss and news on 2026 revenue guidance and acquisition plans, Enpro’s share price has moved up in recent months, with a 30 day share price return of...
NYSE:UMH
NYSE:UMHResidential REITs

A Look At UMH Properties (UMH) Valuation After Recent Share Price Weakness

Why UMH Properties (UMH) Is On Investors’ Radar Today UMH Properties (UMH) has been drawing attention after a mixed stretch in its share performance, with a 1 day return of negative 4.19% and a 1 year total return of negative 15.71%. For investors tracking real estate investment trusts, those numbers sit alongside a past 3 months total return of 1.07% and a 3 year total return of 6.84%, prompting a closer look at what you are actually paying for today. See our latest analysis for UMH...
NYSE:SLGN
NYSE:SLGNPackaging

Did Silgan's 22-Year Dividend Hike Streak Reveal a Deeper Capital Allocation Pivot for SLGN?

Silgan Holdings Inc. previously announced that its Board approved a US$0.21 per share quarterly dividend, payable on March 31, 2026 to shareholders of record on March 17, 2026, representing a 5% increase and extending a streak of 88 consecutive quarterly payments since 2004. This 22-year record of annual dividend increases highlights Silgan’s consistent cash generation and its emphasis on returning capital to shareholders alongside ongoing operational initiatives. We’ll now explore how this...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Is Etsy (ETSY) Now Offering Value After Recent Share Price Rebound?

If you are wondering whether Etsy at around US$54.88 is a bargain or a value trap, this article will help you make sense of what the current share price might be implying. The stock has recently moved, with a 5.2% return over the last 7 days and 3.6% over the last 30 days, while year to date it is at a 4.2% decline and the 3 year and 5 year returns stand at 54.8% and 72.6% declines, with a 7.2% return over the last year. Recent headlines have focused on Etsy’s position as an online...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

How Investors May Respond To Atlanta Braves Holdings (BATR.K) BravesVision Launch and 2025 Earnings Losses

In late February 2026, Atlanta Braves Holdings, Inc. reported fourth-quarter 2025 revenue of US$61.3 million and a net loss of US$41.45 million, alongside full-year 2025 revenue of US$732.49 million and a net loss of US$23.37 million. A day earlier, the company unveiled BravesVision, an in-house multimedia platform that will become the official local television home of the Braves from the 2026 season, giving the organization full control over production, distribution, and monetization of...